Though it has knowhow and wealth, the U.K. has never had much success creating biotechnology startups to rival such U.S. triumphs as Genentech Inc. and Amgen Inc. One explanation for this difference can be summed up in two words: Ronald Reagan.
From her leafy, 11th-floor rooftop terrace at the headquarters of Soho China Ltd ., billionaire Zhang Xin scans the relentlessly expanding Beijing skyline she helped create. Zhang’s avant-garde buildings -- some sleek as chopsticks, others stepped like rice terraces -- became part of the hottest real estate market on Earth in 2010.
The U.K.’s National Health Service considers patents for diagnostics and genes “unacceptable, unenforceable and detrimental to the delivery of patient services” and is deliberately ignoring them, the U.K.’s Financial Times reported.
U.K. Prime Minister David Cameron will attempt today to stop the News of the World phone-hacking scandal inflicting further damage on his government as he faces the biggest crisis since he came to office last year.